EFPIA - NEWSLETTER

EFPIA Newsletter 14 April 2022

New proposals from the research-based pharmaceutical industry should reduce inequalities in patient access to medicines across Europe

Back Innovation, Boost Access

The new pledge from EFPIA member companies should drastically increase the availability of innovative medicines in EU countries and decrease the time patients must wait for new medicines by several months.

EFPIA member companies commit to file for pricing and reimbursement in all EU countries as soon as possible and no later than 2 years from the central EU market authorisation, provided that local systems allow it. The commitment is designed to help deliver faster, more equitable access to medicines for patients across Europe.

Blogs

13 April 2022 DIA Leader of Tomorrow 2022 – bringing students and young professionals closer to the innovative...

Leader of Tomorrow is a community created by DIA that is tailor-made for students and young professionals in life sciences...

Events

07 JUN 2022

Future Clinical Trials conference – from tomorrow to 2030 – Why choose the Nordics?... in Helsinki or virtually

The event will take place in Team Finland House (Porkkalankatu 1, Helsinki). It is also possible to follow the event...

Learn more →

27 JUN 2022

11th European Conference on Rare Diseases & Orphan Products Virtual event

Putting rare diseases policy into action.

Learn more →

We published

Shortening the WAIT - Patient Access to Medicines in Europe 06 April 2022 (News & Events)

Disparities in the time it takes for patients to access new medicines in different EU Member States are increasing.

Are medicines affordable for health systems? The myths, the facts and the way forward 07 April 2022 (News & Events)

Pharmaceutical expenditure has been stable as a share of total healthcare expenditure in all European countries included...

What we are reading

Pharma industry insists European drugs are affordable 07 April 2022 (thepharmaletter)

New EU Portal To Track Pricing & Reimbursement Applications 11 April 2022 (Pink Sheet)

UK launches its ‘Netflix-style’ payment model for antibiotics 12 April 2022 (pharmaphorum)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶